This study aims to evaluate feasibility of a double-blind randomized controlled trial for levetiracetam prophylaxis for prevention of seizure in the perioperative phase of brain tumor resection.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
70
Tablets
Tablets
Recruitment Rate
Feasibility outcome
Time frame: Through study completion, approximately 1 year
Fraction of eligible patients approached
Time frame: Through study completion, approximately 1 year
Fraction of approached patients consent
Time frame: Through study completion, approximately 1 year
Role of individual who approached patients
Description of research team member first approaching and consenting patients (e.g. resident, research staff, staff surgeon, etc.)
Time frame: Through study completion, approximately 1 year
Protocol adherence
Number of participants who withdrawal from the study
Time frame: Through study completion, approximately 1 year
Protocol adherence
Drug adherence rate
Time frame: Through study completion, approximately 1 year
Protocol adherence
Follow-up completion rate
Time frame: Through study completion, approximately 1 year
Protocol adherence
Method of follow-up (e.g. telephone, clinic visit)
Time frame: Through study completion, approximately 1 year
Adverse events
Serious and related adverse events and adverse drug reactions
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Through study completion, approximately 1 year
Unblinding events
Number of events and reasoning
Time frame: Through study completion, approximately 1 year